Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00927264 · ClinicalTrials.gov registry record · NA
PRIDE: Preventing Respiratory Illnesses During Childhood Study
A NA study of Tobacco Smoke Pollution, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT00927264: Completed NA study of Tobacco Smoke Pollution, sponsored by Johns Hopkins University.
NCT00927264 is a NA study of Tobacco Smoke Pollution that has completed, run by Johns Hopkins University. The registered enrollment target is 350 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00927264, a NA study of Tobacco Smoke Pollution, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
Environmental tobacco smoke (ETS0, also known as secondhand smoke, is the combination of smoke given off by the burning end of a tobacco product and the smoke exhaled by the smoker. Children exposed to ETS are at an increased risk of sudden infant death syndrome (SIDS), ear infections, colds, pneumonia, bronchitis and more severe asthma. ETS can also slow the growth of children's lungs and can cause them to cough, wheeze and fell breathless. The purpose of this study is to determine the effectiveness of a motivational interviewing-based program in reducing ETS exposure and improving lung health among children who are enrolled in a Head Start program and whose households include a smoker.
Primary Outcome
Air nicotine levels were an indicator of child's exposure to environmental tobacco smoke (ETS)
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing Intervention for ETS Reduction
- BEHAVIORAL Educational Program for ETS Reduction
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2009-01 |
| Est. Completion | 2013-06 |
| Phase | NA |
What the finished NCT00927264 record still lists
NCT00927264 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Tobacco Smoke Pollution appearing as the primary indexed condition, and to 2 interventions - of which Motivational Interviewing Intervention for ETS Reduction is the first listed.
NCT00927264 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00927264 about?
NCT00927264 is a clinical study titled "PRIDE: Preventing Respiratory Illnesses During Childhood Study". Environmental tobacco smoke (ETS0, also known as secondhand smoke, is the combination of smoke given off by the burning end of a tobacco product and the smoke exhaled by the smoker. Children exposed to ETS are at an increased risk of sudden infant death syndrome (SIDS), ear infections, colds, pneumo...
What is the current status of trial NCT00927264?
This trial is currently completed. It is a NA study. The enrollment target is 350 participants. The study started on 2009-01. Estimated completion is 2013-06.
What conditions does trial NCT00927264 study?
This clinical trial studies the following conditions: Tobacco Smoke Pollution.
What interventions are being tested in trial NCT00927264?
The interventions under investigation include: Motivational Interviewing Intervention for ETS Reduction (BEHAVIORAL), Educational Program for ETS Reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT00927264?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00927264 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00927264's enrollment target sits among peer trials
350 292nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia